ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
| 2024-11-08 8:01:28 AM | Chg. -0.20 | Volume | Bid10:04:48 AM | Ask10:04:48 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 100.40EUR | -0.20% | 0 Turnover: 0.00 |
100.30Bid Size: 60 | 101.25Ask Size: 60 | 20.03 bill.EUR | - | - |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 2,038.6000 | 2,015.4000 | 2,077.4000 | 2,047.7000 | 2,016.5000 | ||||||
| Intangible Assets | 8,353.4000 | 7,684.6000 | 7,257.6000 | 7,055.5000 | 6,299.8000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 21,449.2000 | 19,699.4000 | 19,914.8000 | 19,334.4000 | 18,571.4000 | ||||||
| Inventories | 2,081.8000 | 2,256.5000 | 2,385 | 2,450.7000 | 2,394.5000 | ||||||
| Accounts Receivable | 1,494.6000 | 1,275.8000 | 1,363.9000 | 1,452.7000 | 1,404.9000 | ||||||
| Cash and Cash Equivalents | 524.4000 | 542.8000 | 617.9000 | 802.1000 | 478.5000 | ||||||
| Current Assets | 4,515.3000 | 4,427.4000 | 4,723.9000 | 5,083.3000 | 4,885 | ||||||
| Total Assets | 25,964.5000 | 24,126.8000 | 24,638.7000 | 24,417.7000 | 23,456.4000 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 330.2000 | 362.6000 | 400.9000 | 330 | 351.2000 | ||||||
| Long-term debt | 8,917.5000 | 8,413.7000 | 6,721.4000 | 7,626.5000 | 5,463.7000 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 1,101.5000 | 999.5000 | 840.1000 | 790.4000 | 665.6000 | ||||||
| Liabilities | 14,229 | 12,850.7000 | 12,245.9000 | 12,218.3000 | 10,790 | ||||||
| Share Capital | 3.1000 | 3.1000 | 3.1000 | 3.1000 | 3.1000 | ||||||
| Total Equity | 11,735.5000 | 11,276.1000 | 12,392.8000 | 12,199.4000 | 12,666.4000 | ||||||
| Minority Interests | -.3000 | 4.8000 | 4.7000 | 5.2000 | 5.7000 | ||||||
| Total liabilities equity | 25,964.5000 | 24,126.8000 | 24,638.7000 | 24,417.7000 | 23,456.4000 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 7,824.1000 | 7,932.9000 | 7,982.2000 | 7,024.5000 | 7,836.2000 | ||||||
| Depreciation (total) | 603.9000 | 595.9000 | 584.3000 | 597.6000 | 615.7000 | ||||||
| Operating Result | 808.2000 | 33.8000 | 1,137.5000 | -87.8000 | 780.1000 | ||||||
| Interest Income | 2.2000 | -289.3000 | -226.9000 | -212 | -208.4000 | ||||||
| Income Before Taxes | 464.6000 | -271.1000 | 905.8000 | -274.4000 | 418.4000 | ||||||
| Income Taxes | -1,348.8000 | 108.2000 | -225.7000 | -137 | 16.3000 | ||||||
| Minority Interests Profit | -.4000 | -.1000 | -.1000 | 1.5000 | .5000 | ||||||
| Net Income | 1,813.8000 | -379.2000 | 1,131.6000 | -138.9000 | 401.6000 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,582.3000 | 1,747.4000 | 1,585.8000 | 1,204.5000 | 1,499.2000 | ||||||
| Cash Flow from Investing Activities | -510.8000 | -416.6000 | -729.3000 | -613.8000 | -503.6000 | ||||||
| Cash Flow from Financing | -1,210.5000 | -1,302.2000 | -779.9000 | -421.8000 | -1,306 | ||||||
| Decrease / Increase in Cash | -109.7000 | 18.4000 | 75.1000 | 184.2000 | -323.6000 | ||||||
| Employees | 18,200 | 19,000 | 19,900 | 20,000 | 19,500 | ||||||
